BackInfectious Diseases Manifesting in the Nervous System: Microbiology Study Notes
Study Guide - Smart Notes
Tailored notes based on your materials, expanded with key definitions, examples, and context.
Chapter 20: Infectious Diseases Manifesting in the Nervous System
20.1 The Nervous System, Its Defenses, and Normal Biota
The nervous system is a complex network responsible for sensory input, integration, and motor output. Its unique anatomical and physiological features provide both protection and vulnerability to infectious diseases.
Central Nervous System (CNS): Consists of the brain and spinal cord. Protected by the skull and vertebral column.
Peripheral Nervous System (PNS): Composed of nerves emanating from the CNS to sense organs and peripheral tissues.
Functions of the Nervous System
Sensory: Sensory receptors detect stimuli and transmit impulses to the CNS.
Integrative: CNS processes impulses, resulting in sensation, thought, and motor function.
Motor: Motor impulses control muscles and glands.
Structural Protection
Meninges: Three protective layers surrounding the brain and spinal cord: Dura mater, Arachnoid mater, and Pia mater.
Cerebrospinal Fluid (CSF): Fills the subarachnoid space, provides nutrition, and cushions the CNS.
Blood-Brain Barrier
Specialized endothelial cells restrict passage of most molecules and microbes into the CNS.
Allows freer passage of ions and metabolites elsewhere in the body.
Limits drug and antibiotic access to the CNS.
Immune Defenses in the CNS
Microglial cells: CNS-resident phagocytes.
Brain macrophages: Provide additional immune surveillance.
Phagocytic activity is lower than in other tissues.
Nervous System | Defenses | Normal Biota |
|---|---|---|
CNS & PNS | Bony structures, blood-brain barrier, microglial cells, macrophages | None |
Emerging Microbiome Results
The CNS and PNS are considered sterile; detection of microbes indicates pathology.
Recent research suggests the gut-brain axis: gut microbiota may influence CNS autoimmunity and brain chemistry.
20.2 Infectious Diseases Manifesting in the Nervous System
Numerous microorganisms can infect the nervous system, leading to conditions such as meningitis, encephalitis, and meningoencephalitis. Understanding causative agents, transmission, and prevention is crucial for clinical management.
Meningitis
Definition: Inflammation of the meninges, most often caused by bacteria, viruses, or fungi.
Symptoms: Fever, headache, stiff neck, nausea, vomiting, photophobia, seizures, altered mental status.
Diagnosis: Rapid and accurate diagnosis is essential to prevent mortality.
Pathogenesis: Virulence factors enable pathogens to penetrate the blood-brain barrier.
Major Bacterial Causes of Meningitis
Neisseria meningitidis: Gram-negative diplococcus, epidemic meningitis, virulence via capsule, endotoxins, enzymes.
Streptococcus pneumoniae: Gram-positive, end-to-end pairs, polysaccharide capsule, alpha-hemolysin, hydrogen peroxide, two vaccines available.
Haemophilus influenzae: Gram-negative coccobacillus, "Hib" (serotype B), severe disease, vaccine has reduced incidence.
Listeria monocytogenes: Gram-positive, variable morphology, intracellular growth, resistant to environmental extremes, associated with contaminated food.
Fungal Causes of Meningitis
Cryptococcus neoformans: Encapsulated yeast, chronic meningitis, rapid onset in immunocompromised, transmitted via bird droppings.
Coccidioides spp.: "Valley Fever," dimorphic fungus, endemic in southwestern U.S., true systemic infection.
Viral Meningitis
Most common form in children; 90% caused by enteroviruses.
Other causes: HSV-2, HHV-6, HHV-7, HHV-3, HIV.
Generally milder than bacterial/fungal forms; resolves in ~2 weeks.
Meningitis Disease Table
Causative Organism(s) | Most Common Modes of Transmission | Virulence Factors | Culture/Diagnosis | Prevention | Treatment | Distinctive Features | Epidemiological Features |
|---|---|---|---|---|---|---|---|
Neisseria meningitidis | Droplet contact | Capsule, endotoxin, IgA protease | Gram stain/culture of CSF, blood, rapid antigen tests | Conjugate vaccine, prophylactic antibiotics | Ceftriaxone, penicillin | Petechiae, rapid decline | 14% of bacterial cases; 1,000 cases/year in U.S. |
Streptococcus pneumoniae | Droplet contact | Capsule, alpha-hemolysin, hydrogen peroxide | Gram stain/culture of CSF | Two vaccines | Ceftriaxone, vancomycin | Most common, no petechiae | Highest rates in children & elderly |
Haemophilus influenzae | Droplet contact | Capsule | Culture on chocolate agar | Hib vaccine | Ceftriaxone, rifampin | Serious, acute, less common since vaccine | Virtually eliminated in U.S. |
Listeria monocytogenes | Vehicle (food) | Intracellular growth | Cold enrichment, rapid methods | Cooking food, avoiding unpasteurized dairy | Ampicillin + gentamicin | Asymptomatic in healthy adults, septicemia in neonates | Mortality as high as 33% in symptomatic cases |
Cryptococcus neoformans | Vehicle (air, dust) | Capsule, melanin production | Negative staining, biochemical tests | N/A | Amphotericin B, flucytosine | Acute or chronic, common in AIDS patients | 90% of infections in HIV+ patients |
Coccidioides spp. | Vehicle (air, dust, soil) | Granuloma (spherule) formation | Identification of spherules, cultivation | Avoiding airborne exposure | Fluconazole, amphotericin B | Almost exclusively in endemic regions | 200-300 cases/year in U.S. |
Viruses | Droplet contact | Lytic infection of host cells | Viral culture, antigen tests | N/A | Supportive care | Milder than bacterial/fungal | 26,000-42,000 hospitalizations/year in U.S. |
Neonatal and Infant Meningitis
Transmitted from mother in utero or during birth.
Most common causes: Streptococcus agalactiae (Group B strep), Escherichia coli (K1 strain), Listeria monocytogenes.
Premature infants at higher risk; mortality and morbidity rates vary.
Causative Organism(s) | Most Common Modes of Transmission | Virulence Factors | Culture/Diagnosis | Prevention | Treatment | Distinctive Features | Epidemiological Features |
|---|---|---|---|---|---|---|---|
Streptococcus agalactiae | Vertical (during birth) | Capsule | Culture mother's genital tract, CSF | Culture and treatment of mother | Penicillin G + aminoglycosides | Most common, positive culture of mother | 1.8 cases per 1,000 live births |
Escherichia coli (K1) | Vertical (during birth) | N/A | CSF Gram stain/culture | N/A | Ceftriaxone or cefotaxime | Suspected if infant is premature | 20% mortality in premature infants |
Listeria monocytogenes | Vertical | Intracellular growth | Cold enrichment, rapid methods | Cooking food, avoiding unpasteurized dairy | Ampicillin + gentamicin | Mortality as high as 33% in symptomatic cases | Rare but deadly |
Cronobacter sakazakii | Vehicle (baby formula) | Ability to survive dry conditions | Culture on rapid chromogenic agar | Safe preparation of formula | Supportive care | Rare, outbreaks in neonatal units | Few cases, but high mortality |
Meningoencephalitis
Definition: Inflammation of both the brain and meninges.
Causative agents: Amoebas such as Naegleria fowleri and Acanthamoeba.
Causative Organism(s) | Most Common Modes of Transmission | Virulence Factors | Culture/Diagnosis | Prevention | Treatment | Epidemiological Features |
|---|---|---|---|---|---|---|
Naegleria fowleri | Vehicle (freshwater exposure) | Invasiveness | CSF exam, brain imaging | Avoid untreated water entering nasal passages | Pentamidine, sulfadiazine | 7 cases/year in U.S., mostly southern states |
Acanthamoeba | Direct contact | Invasiveness | CSF exam, biopsy | N/A | Surgical excision, pentamidine | Immunocompromised patients |
Additional info:
Further sections in the chapter (not shown in these slides) would cover viral encephalitis, prion diseases, and other nervous system infections such as rabies, polio, tetanus, botulism, and African sleeping sickness, each with their causative agents, transmission, prevention, and treatment.